Néphrotoxicité de l'amphotéricine B : mise au point

[1]  A. Antoniadou,et al.  Lipid formulations of amphotericin B: where are we today? , 2005 .

[2]  J. Ito,et al.  Treatment of Candida infections with amphotericin B lipid complex. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  B. Alexander,et al.  Study of renal safety in amphotericin B lipid complex-treated patients. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  D. Bamberger,et al.  Safety and Efficacy of Liposomal Amphotericin B Compared with Conventional Amphotericin B for Induction Therapy of Histoplasmosis in Patients with AIDS , 2002, Annals of Internal Medicine.

[5]  S. Pestotnik,et al.  The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. , 2001, The American journal of medicine.

[6]  D. Bates,et al.  Mortality and costs of acute renal failure associated with amphotericin B therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  E. Anaissie,et al.  A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia , 2000 .

[8]  E. Anaissie,et al.  Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  R. Finberg,et al.  Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia , 1999 .

[10]  S. Bhakdi,et al.  Possible reason for preferential damage to renal tubular epithelial cells evoked by amphotericin B , 1996, Antimicrobial agents and chemotherapy.

[11]  R. Pollard,et al.  Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Schnermann,et al.  Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties. , 1995, Journal of the American Society of Nephrology : JASN.

[13]  U. Biswas,et al.  Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar , 1994, The Lancet.

[14]  M. Levenstein,et al.  A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia , 1994 .

[15]  M. Brezis,et al.  Chronic amphotericin nephropathy: morphometric, electron microscopic, and functional studies. , 1993, Journal of the American Society of Nephrology : JASN.

[16]  M. Brezis,et al.  In-vivo and in-vitro studies on the effect of amphotericin B on endothelin release. , 1992, The Journal of antimicrobial chemotherapy.

[17]  W. R. Campbell,et al.  Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity in rats. , 1991, The Journal of clinical investigation.

[18]  B. Strom,et al.  Risk factors for Amphotericin B-associated nephrotoxicity. , 1989, The American journal of medicine.

[19]  D. Smith,et al.  Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS). , 1989, Annals of internal medicine.

[20]  S. Chuck,et al.  Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. , 1989, The New England journal of medicine.

[21]  N. Vaziri,et al.  Renal magnesium wasting associated with amphotericin B therapy. , 1984, The American journal of medicine.

[22]  M. Brezis,et al.  Polyene toxicity in renal medulla: injury mediated by transport activity. , 1984, Science.

[23]  R. Branch,et al.  Amphotericin B nephrotoxicity in humans decreased by salt repletion. , 1983, The American journal of medicine.

[24]  R. R. Robinson,et al.  Amphotericin B nephrotoxicity: increased renal resistance and tubule permeability. , 1982, Kidney international.

[25]  J. Elkinton,et al.  Renal tubular acidosis due to amphotericin B. , 1968, The New England journal of medicine.